Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPM2 | O94759 | 6/20 | 0.48 |
| ▸ | LTB4R | Q15722 | 4/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.45 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.45 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.43 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4833179 | 1.00 | TRPM2 (0.48) | TRPM2LTB4RTRPA1MAPTNPC1 | |
| SCHEMBL4833501 | 1.00 | TRPM2 (0.48) | TRPM2LTB4RTRPA1MAPTNPC1 | |
| SCHEMBL4828886 | 0.94 | TRPV1 (0.46) | TRPM2LTB4RTRPA1MAPTNPC1 | |
| SCHEMBL4828867 | 0.94 | TRPV1 (0.46) | TRPM2LTB4RTRPA1MAPTNPC1 | |
| SCHEMBL4828878 | 0.94 | TRPV1 (0.46) | TRPM2LTB4RTRPA1MAPTNPC1 | |
| SCHEMBL4833874 | 0.90 | PLK1 (0.47) | MAPTNPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL4833858 | 0.90 | PLK1 (0.47) | MAPTNPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL4833312 | 0.84 | PLK1 (0.52) | MAPTNPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL4833302 | 0.84 | PLK1 (0.52) | MAPTNPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL4833885 | 0.84 | ALDH1A1 (0.44) | MAPTNPC1RAB9ASMN1; SMN2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7420083-B2 | Substituted aryloximes | WYETH (US) | 2008-09-02 | — | — | US | claimed |
| US-20050070584-A1 | Substituted aryloximes | WYETH (US) | 2005-03-31 | — | — | US | claimed |
| US-20080293790-A1 | SUBSTITUTED ARYL OXIMES | WYETH (US) | 2008-11-27 | — | — | US | disclosed |
| US-7420083-B2 | Substituted aryloximes | WYETH (US) | 2008-09-02 | — | — | US | disclosed |
| US-20050070584-A1 | Substituted aryloximes | WYETH (US) | 2005-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050070584-A1 | Substituted aryloximes | AHR, NQO1, AOX1 | TRPM2 4568/4885LTB4R 732/4885TRPA1 2718/4885 |
| US-20080293790-A1 | SUBSTITUTED ARYL OXIMES | HCCS, AOX1, TET2 | TRPM2 4793/4885LTB4R 1339/4885TRPA1 4014/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.